Mr Manuel L. Montinola, General Director of United International Pharma, talks about the company's cooperation with VET and how it's led the way in the Vietnam.
United International Pharma (UIP) has collaborated with Vietnam Economic Times (VET) and been honoured with a Golden Dragon Award for a number of years in succession. Can you tell us more about this partnership?
UIP has participated in the Golden Dragon Awards since 2003 by winning an Award every year. Thanks to VET, UIP was able to prove its merit and performance to its partners, customers and the public. VET provides readers with up-to-date information on the achievement of foreign investors in general and of UIP in particular, which encourages us to continue to strive for excellence and best practice.
How has UIP become a leader in the pharmaceutical industry?
UIP’s achievements over recent years saw it take the lead in the pharmaceutical industry by adopting the right strategy in partnering with stakeholders from the government, the medical community and trading institutions, as well as in providing consumers with high quality products. UIP also invested in a new factory at the Vietnam-Singapore Industrial Park II and has affirmed its commitment to contributing to a “Healthier and Wealthier Vietnam” with the world class Pharmaceutical Inspectorate Cooperation Scheme (PICS) standard factory. Everything we do we do passionately, because health is our most valuable asset.
What are your plans in Vietnam in the future?
Our plan for developing in Vietnam in the time to come is to continue providing pharmaceutical products and services with high quality and affordable prices in order to improve people’s health and enrich the lives of the community. We will also be actively involved in improving the quality life in Vietnam through CSR (Corporate Social Responsibility) programmes. These activities are entirely consistent with UIP’s mantra, “United for health, United for life”.